PubMed · 1995 · 112 citations · 26 references
MedicineMolecular BiologyOncologyGene DeliveryGene TherapyMolecular OncologyCancer BiotechnologyGene Delivery VectorsMessenger Rna DeliveryOncogenic VirusesRas Family OncogenesTargeted Cancer TherapyAdenoviral VectorsAdenovirus VectorsCodon 12 MutationsHammerhead Ribozyme CleavageHammerhead RibozymesNeoplastic DiseaseRas-targeted TherapiesRibozymes
Strategies have been developed to abrogate the aberrant expression of dominant oncogenes as a means to accomplish targeted tumor eradication. We have demonstrated previously the utility of this approach using a hammerhead ribozyme designed to cleave the mutant sequence in codon 12 of the activated H-ras oncogene transcript. To develop this strategy into a practical means to approach malignant disease, methods must be developed to accomplish high efficiency delivery of the ribozyme to target neoplastic cells. To accomplish this, a recombinant adenovirus was designed that encoded a gene cassette for the H-ras ribozyme. By using this virus, it was possible to accomplish high efficiency reversion of the neoplastic phenotype in mutant H-ras expressing tumor cells without the need for any selection steps. The demonstration of the utility of adenoviral-mediated delivery of anticancer ribozymes will allow the practical development of gene therapy strategies on this basis.
26
Ribozymes as Potential Anti-HIV-1 Therapeutic Agents
Nava Sarver, Edouard M. Cantin, Pairoj S. Chang et al. · Science · 1990 · 663 citations
Antisense RNA-Induced Reduction in Murine TIMP Levels Confers Oncogenicity on Swiss 3T3 Cells
Rama Khokha, Paul Waterhouse, Simcha Yagel et al. · Science · 1989 · 457 citations
Medicine, Cancer Biology, Oncology +10